There is a shift in focus from molecular drugs to protein based drugs in pharmaceutical industry. Protein drugs are artificially synthesized protein used in treatment of chronic diseases such as cancer, diabetes and CVD. Globally, development the arena of proteomics and nanotechnology, rising incidences of chronic and autoimmune diseases, rise in the awareness among people regarding protein drugs, increasing focus on research and development process, development in drug delivery system, and advantages of protein based drugs such as, high specificity, enhanced efficacy, affinity, solubility, and low incidences of toxicity are the prime growth drivers of protein drugs market. In addition, increase in adoption of protein drugs in emerging economies such as China, India and others, will create new opportunities for global protein drugs market. However, higher cost of the research and development, and complex government approval processes are the key restraints for protein drugs market.
Geographically North America dominated global protein drugs market, with approximately half of the market in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing population chronic and autoimmune diseases patient in developing nations such as China, and India in this region. Among all the types, antibody segment has the highest market share in global protein drugs market due to higher prevalence of cancer patients.
This report identifies the global protein drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global protein drugs market.
This report segments global protein drugs market on the basis of type and regional market as follows:
- Protein Drugs Market, By Type: Antibody Drugs, Peptide Hormones, Blood Products, and Enzymes
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the protein drugs market. Some of the major companies’ profiles in detail are as follows:
- Eli Lilly
- Abbott Laboratories
- UCB Group
- Schering-Plough Corporation
- Genentech Inc.